Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
- First Posted Date
- 2004-06-18
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 22
- Registration Number
- NCT00005829
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Interventions
- First Posted Date
- 2004-06-17
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 93
- Registration Number
- NCT00003996
- Locations
- 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸CCOP - Wichita, Wichita, Kansas, United States
🇺🇸CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 34
- Registration Number
- NCT00003829
- Locations
- 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸Quain & Ramstad Clinic, P.C., Bismarck, North Dakota, United States
🇺🇸CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
- Conditions
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 56
- Registration Number
- NCT00003381
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
🇺🇸CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
🇺🇸Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Registration Number
- NCT00085449
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma
- First Posted Date
- 2004-06-10
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 36
- Registration Number
- NCT00002676
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CCOP - Kalamazoo, Kalamazoo, Michigan, United States
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-06-03
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 38
- Registration Number
- NCT00004055
- Locations
- 🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸CentraCare Clinic, Saint Cloud, Minnesota, United States
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 51
- Registration Number
- NCT00005059
- Locations
- 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
- Conditions
- Interventions
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 43
- Registration Number
- NCT00002806
- Locations
- 🇺🇸
CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸Siouxland Hematology-Oncology, Sioux City, Iowa, United States
Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 80
- Registration Number
- NCT00004139
- Locations
- 🇺🇸
CCOP - Greenville, Greenville, South Carolina, United States
🇺🇸Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸Walter Reed Army Medical Center, Washington, District of Columbia, United States